CoChat

ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS

Gillberg, Christopher · 1995 · Developmental Medicine & Child Neurology
Cited by 82

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

SUMMARY: Endogenous opioid dysfunction hypotheses for the development of autism are reviewed, along with clinical empirical studies of opiate antagonists in autism and self‐injurious behaviour. There is not yet sufficient evidence to suggest the use of opiate antagonists in the treatment of autism. Further research, particularly of natrexone in severe self‐injury, is warranted. RÉSUMÉ: Endorphines el antagonistes des opiacés dans l'autisme: une brève revue des données empiriques el des implications pour les enfants Une brève revue est faite, des hypothèses sur un dysfonctionnement des endorphines dans le développement de l'autisme, ainsi que des études cliniques sur l'action des antagonistes d'opiaces dans l'autisme et les comportement d'auto‐agression. II n'y a pas encore d'évidences suffisantes pour conseiller l'utilisation des antagonistes d'opiacés dans le traitement de l'autisme. Des recherches ultérieures, notamment sur l'action de la naltrexone dans l'auto‐agression grave, sont indispensables. ZUSAMMENFASSUNG: Endogene Opioide und Opiat‐Antagonisten bei Auiismus: ein kurzer Überblick über die empirischen Befunde und die Schluβfolgerungen für Kinder Es werden die Hypothesen einer endogenen Opioiddysfunktion als Ursache für die Entwicklung eines Autismus im Zusammenhang mit klinisch‐empirischen Studien über die Wirkung von Opiat‐Antagonisten bei Autismus und selbstverstummelndem Verhalten überprüft. Es gibt noch keine ausreichenden Befunde, um Opiat‐Antagonisten für die Therapie des Autismus empfehlen zu können. Weitere Untersuchungen sind erforderlich, insbesondere mit Naltrexon bei schwerem selbstverstümmelndem Verhalten. RESUMEN: Opioides endógenos y antagonistas del opio en el autismo: breve revisión de los hallazgos empíricos y sus implicaciones en niños Se revisa la hipótesis de la disfunción en los opioides endógenos en el desarrollo de autismo, asi como los estudios clinicos empiricos sobre antagonistas del opio en el autismo y en el comportamiento autoagresivo. Todavia no hay suficiente evidencia para sugerir el uso de los antagonistas del opio en el tratamiento del autismo. Está justificado el proseguir con los estudios, especialmente de la naltrexone en los casos de grave autoagresión.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1469-8749.1995.tb11998.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 82

Metadata

Authors
Gillberg, C.
Venue
Developmental Medicine & Child Neurology
Publisher
Wiley
Published
1995-03
Volume
37
Issue
3
Pages
239-245
ISSN
  • 0012-1622 (ISSN-L)
  • 1469-8749
OpenAlex
W2126320656
Cited by
82
References
4
FWCI
2.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS. https://app.cochat.ai/papers/10.1111/j.1469-8749.1995.tb11998.x
The paper
Gillberg, C. (1995). ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1995.tb11998.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.